NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Patients will be included with a stable but active disease (as defined Diagnosis of systemic
sclerosis according to ACR/EULAR classification by EUSTAR ≥2.5) or to patients with a
worsening disease despite low dose steroids and at least 2 immunosuppressive treatment
including DMARDs (methotrexate, azathioprine, mycophenolate mofetil) and/or a biological
DMARD (rituximab or tocilizumab) for at least 6 months.
1 total trials
Filter these 1 trials by phase, country, sponsor and more.